The Top 10 Revenue-Generating Peptide Treatments for Med Spas in 2026

The peptide therapy market for med spas has matured significantly, and the data on which treatments generate the strongest returns is now clear enough to guide strategic treatment menu decisions. While the total addressable market for peptide therapies continues to expand rapidly, not all peptides deliver equal revenue potential, patient satisfaction, or operational efficiency for med spa settings. This analysis ranks the top ten revenue-generating peptide treatments for med spas in 2026 based on a combination of per-treatment revenue, treatment frequency and patient retention rates, patient demand and conversion rates, sourcing accessibility and cost of goods, and operational complexity. Each entry includes practical insights on pricing, protocols, and sourcing to help you evaluate these treatments for your own practice.

Semaglutide remains the undisputed revenue leader for med spas in 2026, driven by extraordinary patient demand for medical weight management solutions. The average med spa offering semaglutide therapy generates between thirty and fifty thousand dollars per month in semaglutide-specific revenue, with top-performing clinics exceeding one hundred thousand dollars monthly. Treatment protocols typically involve weekly subcutaneous injections with gradual dose titration from 0.25 milligrams to maintenance doses of 1.0 to 2.4 milligrams over twelve to sixteen weeks. Monthly treatment pricing ranges from four hundred to eight hundred dollars depending on market and dosing, with package programs for twelve to twenty-four week courses improving both patient commitment and revenue predictability. Sourcing semaglutide API requires careful attention to purity specifications and regulatory compliance, making verified supplier platforms like oriGENapi particularly valuable for this high-stakes category.

Tirzepatide has rapidly ascended to the number two position and is closing the gap with semaglutide in many markets. Its dual GIP and GLP-1 receptor agonist mechanism delivers superior average weight loss outcomes, making it the preferred option for patients with higher BMI starting points or those who have plateaued on semaglutide. Monthly treatment pricing for tirzepatide typically runs ten to twenty percent higher than comparable semaglutide programs, reflecting both the higher API cost and the enhanced efficacy positioning. Med spas offering both semaglutide and tirzepatide can capture a broader patient population and provide step-up options for patients seeking more aggressive weight loss. The API supply chain for tirzepatide is less mature than semaglutide, so building relationships with multiple qualified suppliers is particularly important for this compound.

BPC-157, or Body Protection Compound-157, has emerged as the leading peptide therapy for recovery, healing, and gut health applications in med spa settings. This pentadecapeptide has generated intense patient interest due to research suggesting benefits for tendon and ligament healing, gastrointestinal repair, and anti-inflammatory effects. Med spas typically offer BPC-157 as part of recovery and wellness protocols, with pricing ranging from two hundred to four hundred dollars per month for injection-based programs and slightly less for oral formulations. The treatment appeals to a different demographic than weight management peptides, primarily active adults, athletes, and patients with chronic musculoskeletal or gastrointestinal complaints. BPC-157 programs show strong retention rates, with many patients continuing treatment for three to six months or longer, making it an excellent recurring revenue driver.

NAD+ (nicotinamide adenine dinucleotide) infusion therapy and its precursor peptide protocols represent a high-margin treatment category with strong patient demand in the anti-aging and wellness segments. While technically a coenzyme rather than a peptide, NAD+ therapy is commonly positioned alongside peptide treatments in med spa settings and generates comparable or superior revenue per session. Intravenous NAD+ infusions typically command three hundred to seven hundred dollars per session, with recommended protocols of two to four sessions initially followed by monthly maintenance. The high per-session price point, combined with the experiential nature of the infusion process, makes NAD+ therapy a signature offering that enhances the perceived sophistication and clinical capability of your med spa.

PT-141, also known as bremelanotide, targets the sexual wellness market and fills a distinctive niche in the med spa treatment menu. As a melanocortin receptor agonist that addresses sexual dysfunction through central nervous system pathways rather than vascular mechanisms, PT-141 appeals to both male and female patients who have not responded to or prefer alternatives to traditional sexual health medications. Treatment pricing ranges from one hundred fifty to three hundred fifty dollars per dose, with patients typically self-administering subcutaneous injections as needed. The sensitive nature of sexual wellness drives patients to seek treatment in the private, comfortable environment that med spas provide rather than in traditional clinical settings, giving med spas a natural competitive advantage in this category.

CJC-1295 with DAC, a growth hormone-releasing hormone analog, maintains strong demand among patients seeking anti-aging, body composition improvement, and performance enhancement benefits. Often paired with ipamorelin as a synergistic combination, CJC-1295 protocols generate revenue through both the initial treatment phase and extended maintenance programs. Monthly pricing for CJC-1295 and ipamorelin combination therapy ranges from three hundred to six hundred dollars, with most protocols running three to six months initially followed by ongoing maintenance for patients who wish to sustain benefits. This peptide combination appeals particularly to health-conscious patients aged thirty-five to sixty who are proactively investing in longevity and vitality, a demographic with high lifetime value across your full service menu.

GHK-Cu, a copper peptide with demonstrated wound healing, anti-inflammatory, and skin remodeling properties, has found its strongest med spa application in premium skincare treatments and post-procedure recovery protocols. Unlike systemically administered peptides, GHK-Cu is often used topically in serums and creams or delivered through microneedling procedures, which aligns naturally with existing med spa aesthetic workflows. Treatment pricing for GHK-Cu-enhanced procedures ranges from two hundred to five hundred dollars per session, with series of three to six treatments recommended. The integration of GHK-Cu into existing microneedling or mesotherapy offerings enhances the value proposition of these already-popular procedures while differentiating your treatments from competitors using standard serums.

Thymosin Beta-4, known for its roles in tissue repair, wound healing, and anti-inflammatory modulation, occupies a growing niche in the med spa recovery and regenerative medicine space. Treatment protocols typically involve subcutaneous injections administered two to three times per week during an initial loading phase followed by a maintenance schedule. Monthly pricing ranges from two hundred fifty to five hundred dollars, with treatment courses typically lasting four to twelve weeks depending on the clinical indication. Thymosin Beta-4 is frequently combined with BPC-157 in synergistic recovery protocols, creating bundled treatment packages that increase per-patient revenue while potentially improving clinical outcomes. The patient profile for Thymosin Beta-4 overlaps significantly with BPC-157, allowing efficient cross-selling between these complementary peptides.

Epithalon, a synthetic tetrapeptide based on the natural pineal gland peptide epithalamin, has captured the attention of the longevity and anti-aging market segment. Research suggesting telomerase activation and potential telomere lengthening has driven patient demand among affluent, health-optimization-focused consumers. Treatment protocols typically involve ten to twenty-day courses of daily subcutaneous injections, repeated two to three times per year. Per-course pricing ranges from eight hundred to two thousand dollars, making Epithalon one of the highest per-course revenue generators on this list. While the evidence base for Epithalon's anti-aging benefits continues to develop, patient demand is driven by the longevity optimization trend and the willingness of this demographic to invest aggressively in potential health span extension.

Selank and Semax, two regulatory peptide complexes originally developed in Russia, round out the top ten as emerging entries in the cognitive enhancement and stress management category. These intranasal peptides appeal to high-performing professionals, entrepreneurs, and executives seeking cognitive optimization, anxiety reduction, and stress resilience. Monthly treatment pricing ranges from one hundred fifty to three hundred dollars for nasal spray formulations. While the per-unit revenue is lower than many other peptides on this list, the ease of administration, the growing demand for nootropic and stress management solutions, and the recurring nature of these treatments make them worthwhile additions to a comprehensive peptide therapy menu. The cognitive wellness category also attracts a demographic with high disposable income and an appetite for comprehensive wellness services.

Sourcing strategy for a comprehensive peptide treatment menu requires balancing breadth of offering with supply chain manageability. Rather than attempting to source all ten peptides simultaneously, prioritize adding peptides in phases based on patient demand in your market, API availability and supplier reliability, regulatory clarity in your state, alignment with your existing clinical capabilities, and revenue potential relative to operational complexity. For each peptide you add, identify at least two qualified API suppliers to mitigate supply disruption risk. Platforms like oriGENapi simplify this process by providing access to verified suppliers across multiple peptide categories with transparent pricing, quality documentation, and supply reliability data that supports informed sourcing decisions.

Revenue optimization across your peptide treatment menu comes from strategic bundling, protocol design, and lifecycle management. Design treatment packages that combine complementary peptides, such as semaglutide for weight loss with BPC-157 for gut health support, or CJC-1295 with ipamorelin for anti-aging with GHK-Cu treatments for skin rejuvenation. Implement a patient journey framework that introduces patients to one peptide therapy and progressively educates them about complementary options based on their individual health goals. Track per-patient revenue across all peptide treatments to identify your highest-value patient segments and design retention strategies that keep these patients engaged with your practice long term. The most profitable med spa peptide programs in 2026 generate fifty to seventy percent of their revenue from patients using two or more peptide therapies concurrently.